![Respuesta completa tras tratamiento con carfilzomib en segunda línea de tratamiento en paciente con mieloma múltiple IgG kappa. Respuesta completa tras tratamiento con carfilzomib en segunda línea de tratamiento en paciente con mieloma múltiple IgG kappa.](https://academmia.redamgen.com/~/media/Project/ARC_ES/Caso%20pages/IMG-Mujer%20De%2050%20a%2070%20anos.png)
Respuesta completa tras tratamiento con carfilzomib en segunda línea de tratamiento en paciente con mieloma múltiple IgG kappa.
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Immunofluorescence with kappa light chains: monotypic kappa light chain... | Download Scientific Diagram Immunofluorescence with kappa light chains: monotypic kappa light chain... | Download Scientific Diagram](https://www.researchgate.net/publication/263294297/figure/fig4/AS:214040640004115@1428042673894/Immunofluorescence-with-kappa-light-chains-monotypic-kappa-light-chain-deposits-in-the.png)
Immunofluorescence with kappa light chains: monotypic kappa light chain... | Download Scientific Diagram
![Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram](https://www.researchgate.net/publication/292707470/figure/fig4/AS:669620646187022@1536661411380/Measurement-of-kappa-and-lambda-light-chains-in-free-and-total-assays-Total-light.png)
Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram
![Mieloma múltiplo: quem está mais em risco e como identificar? | Vida Saudável | Conteúdos produzidos pelo Hospital Israelita Albert Einstein Mieloma múltiplo: quem está mais em risco e como identificar? | Vida Saudável | Conteúdos produzidos pelo Hospital Israelita Albert Einstein](https://vidasaudavel.einstein.br/wp-content/uploads/2022/03/mieloma-multiplo-cancer-scaled.jpg)
Mieloma múltiplo: quem está mais em risco e como identificar? | Vida Saudável | Conteúdos produzidos pelo Hospital Israelita Albert Einstein
![Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model](https://www.mdpi.com/cells/cells-09-02666/article_deploy/html/images/cells-09-02666-g001.png)